bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • Arbutus Biopharma Corp logo

    Arbutus Biopharma Corp

    ABUS | NASDAQ
    Chart Builder DCF Calculator
    $5
    -$0.01 (-0.20%)
    At close: Sep 21, 2026, 4:00 PM ET
    $5
    $0 (0.00%)
    Pre-market: Sep 22, 2026, 6:34 AM ET
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $989.66M
    Enterprise Value
    $898.69M
    Beta
    0.62
    Average Volume
    2.44M
    Shares Outstanding (Diluted)
    197.47M
    Shares Change YoY
    2.64%
    Institutional Ownership
    71.73%
    Exchange
    NASDAQ
    ISIN
    CA03879J1003

    Price Performance

    Price Change 1M
    -3.9%
    Price Change 3M
    12.4%
    Price Change 6M
    10.4%
    Price Change YTD
    4.8%
    Price Change 1Y
    12.9%
    Price Change 3Y
    159.1%
    Price Change 5Y
    8.2%
    1M CAGR (ann.)
    10.3%
    1Y CAGR (ann.)
    13.1%
    5Y CAGR (ann.)
    2.7%
    All-Time CAGR
    -1.2%

    Valuation

    PE Ratio
    6.41
    Forward PE
    N/A
    PEG Ratio
    0.01
    Forward PEG
    -0.06
    PS Ratio
    5.44
    Forward PS
    240.90
    PB Ratio
    3.82
    P/FCF Ratio
    -40.11
    P/Adj. FCF Ratio
    -32.78
    P/OCF Ratio
    -41.67
    EV/Sales
    4.95
    EV/EBIT
    5.87
    EV/EBITDA
    5.87
    EV/FCF
    -36.49
    Earnings Yield
    15.6%
    FCF Yield
    -2.5%
    Adj. FCF Yield
    -3.0%

    Financial Health

    Net Cash
    $89.51M
    Total Debt
    $3.63M
    Cash & Short-Term Investments
    $92.63M
    Total Assets
    $274.03M
    Current Ratio
    81.42
    Quick Ratio
    81.42
    Debt / Equity Ratio
    0.01
    Debt / EBITDA
    0.02
    Debt / FCF
    -0.15
    OCF / Debt
    -6.79
    Interest Coverage
    1,937.05
    Altman Z-Score
    36.31
    Piotroski F-Score
    6

    Margins & Profitability

    Gross Profit Margin
    100.0%
    Operating Profit Margin
    81.0%
    EBITDA Margin
    84.3%
    Net Profit Margin
    84.2%
    FCF Margin
    -13.6%
    Adj. FCF Margin
    -16.6%
    SBC / Revenue
    3.0%
    SBC Impact (per share)
    -22.4%

    Returns

    Return on Assets
    55.9%
    Return on Equity
    91.0%
    Return on Invested Capital
    54.3%
    Return on Capital Employed
    54.4%
    Return on Tangible Assets
    55.9%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    97.7%
    Revenue CAGR 5Y
    85.2%
    Revenue CAGR 10Y
    26.3%
    EPS CAGR 3Y
    3050.0%
    EPS CAGR 5Y
    146.5%
    EPS CAGR 10Y
    35.8%
    FCF CAGR 3Y
    46.0%
    FCF CAGR 5Y
    8.2%
    FCF CAGR 10Y
    2.9%

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    10
    EPS Growth Next 3Y
    -24.5%
    Revenue Growth Next 3Y
    -1.5%
    Earnings Date
    Nov 15, 2026
    EPS Estimate (next Q)
    -$0.02
    EPS Growth Est (next Q)
    -42.0%
    Revenue Est (next Q)
    $1M
    Revenue Growth Est (next Q)
    89.0%

    Fair Value Estimates

    Graham Number
    $4.79
    Graham Upside
    -4.2%
    Lynch Fair Value
    $19.50
    Lynch Upside
    290.0%
    Price Target
    $8.50
    Price Target Upside
    70.0%

    Cash Flow

    Operating Cash Flow
    $-24.63M
    Free Cash Flow
    $-24.63M
    Adj. Free Cash Flow
    $-30.13M
    FCF Per Share
    -$0.12
    OCF Per Share
    -$0.12
    OCF/S Ratio
    -13.6%

    Income Statement

    Revenue
    $181.72M
    Gross Profit
    $181.69M
    Operating Income
    $147.22M
    EBITDA
    $153.17M
    Net Income
    $153.05M
    EPS (Diluted)
    $0.78
    Revenue / Employee
    $9.56M
    Profit / Employee
    $8.06M
    Employees
    19

    © 2026 bestshares.com. All rights reserved.